These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 17181148

  • 21. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
    da Cunha EF, Sippl W, de Castro Ramalho T, Ceva Antunes OA, de Alencastro RB, Albuquerque MG.
    Eur J Med Chem; 2009 Nov; 44(11):4344-52. PubMed ID: 19616874
    [Abstract] [Full Text] [Related]

  • 22. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.
    Chen Y, Li H, Tang W, Zhu C, Jiang Y, Zou J, Yu Q, You Q.
    Eur J Med Chem; 2009 Jul; 44(7):2868-76. PubMed ID: 19136179
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
    Zhu YQ, Lei M, Lu AJ, Zhao X, Yin XJ, Gao QZ.
    Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
    [Abstract] [Full Text] [Related]

  • 27. 3D-QSAR studies on the inhibitors of AP-1 and NF-kappaB mediated transcriptional activation.
    Qin J, Liu H, Li J, Ren Y, Yao X, Liu M.
    Eur J Med Chem; 2009 Jul; 44(7):2888-95. PubMed ID: 19128859
    [Abstract] [Full Text] [Related]

  • 28. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.
    Xue CX, Cui SY, Liu MC, Hu ZD, Fan BT.
    Eur J Med Chem; 2004 Sep; 39(9):745-53. PubMed ID: 15337287
    [Abstract] [Full Text] [Related]

  • 29. 3D-QSAR CoMFA/CoMSIA studies on Urokinase plasminogen activator (uPA) inhibitors: a strategic design in novel anticancer agents.
    Bhongade BA, Gadad AK.
    Bioorg Med Chem; 2004 May 15; 12(10):2797-805. PubMed ID: 15110861
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. 3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment.
    Ryu CK, Lee Y, Park SG, You HJ, Lee RY, Lee SY, Choi S.
    Bioorg Med Chem; 2008 Nov 15; 16(22):9772-9. PubMed ID: 18930405
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives.
    Basu A, Jasu K, Jayaprakash V, Mishra N, Ojha P, Bhattacharya S.
    Eur J Med Chem; 2009 Jun 15; 44(6):2400-7. PubMed ID: 19000644
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacophore and docking-based combined in-silico study of KDR inhibitors.
    Pasha FA, Muddassar M, Neaz MM, Cho SJ.
    J Mol Graph Model; 2009 Aug 15; 28(1):54-61. PubMed ID: 19447057
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
    Yi P, Fang X, Qiu M.
    Eur J Med Chem; 2008 May 15; 43(5):925-38. PubMed ID: 17698256
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.